Clinical analysis of anticipated drug interactions in HIV/AIDS patients with co-morbidities
- At: 2013 FIP Congress in Dublin (Ireland)
- Type: Poster
- By: THOMAS, Dixon (Anantapur, India)
- Co-author(s): Umesh, K. (Department of Pharmacy Practice, Raghavendra Institute of Pharmaceutical Educati, Anantapur, India)
Padmanabha Reddy, Y. (Department of Pharmacy Practice, Raghavendra Institute of Pharmaceutical Educati, Anantapur, India)
Background : One of the classes of medicines which causes higher numbers of Drug-Drug Interactions (DDIs) and adverse drug outcomes are Antiretroviral (ARV) drugs. The potential for ARV in interacting with each other as well as with other classes of medicines used for common co-morbidities in HIV/AIDS patients are challenging.
Aims: The aim and.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.